Auxilium Pharmaceuticals, Inc. (AUXL) Reports Q4 Loss of $0.25, Offers FY12 Sales Guidance
Tweet
Share
E-mailGet Alerts AUXL Hot Sheet
Price: $36.47 --0%
Financial Fact:
Loss from operations: -23.2M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Loss from operations: -23.2M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q4 EPS of ($0.25), $0.09 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $73.3 million versus the consensus estimate of $73.53 million.
Auxilium Pharmaceuticals, Inc. sees FY2012 revenue of $283-$305 million, versus the consensus of $301.76 million.
For earnings history and earnings-related data on Auxilium Pharmaceuticals, Inc. (AUXL) click here.
Auxilium Pharmaceuticals, Inc. sees FY2012 revenue of $283-$305 million, versus the consensus of $301.76 million.
For earnings history and earnings-related data on Auxilium Pharmaceuticals, Inc. (AUXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
